J. Chesko

发表

Anionic microparticles are a potent delivery system for recombinant antigens from Neisseria meningitidis serotype B.

M. Pizza, M. Giuliani, Manmohan J. Singh, 2004, Journal of pharmaceutical sciences.

Adjuvanted pandemic influenza vaccine: variation of emulsion components affects stability, antigen structure, and vaccine efficacy

R. Coler, S. Reed, T. Vedvick, 2012, Influenza and other respiratory viruses.

UV photodissociation dynamics of allyl radical by photofragment translational spectroscopy

Xueming Yang, Yuan-Pern Lee, A. Suits, 1998 .

Photodissociation of ozone at 193 nm by high-resolution photofragment translational spectroscopy

Xueming Yang, A. Suits, D. Stranges, 1995 .

Development of Biophysical Assays to Better Understand Adjuvanted Vaccine Formulation Potency and Stability

S. Reed, T. Vedvick, J. Chesko, 2013 .

Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency.

Manmohan J. Singh, M. Ugozzoli, J. Kazzaz, 2006, Journal of controlled release : official journal of the Controlled Release Society.

Quantum symmetry and photoreactivity of azabenzenes

J. Chesko, 1995 .

Charged polylactide co-glycolide microparticles as antigen delivery systems

Manmohan J. Singh, M. Ugozzoli, J. Kazzaz, 2004, Expert opinion on biological therapy.

A practical approach to the use of nanoparticles for vaccine delivery.

Manmohan J. Singh, M. Ugozzoli, J. Kazzaz, 2006, Journal of pharmaceutical sciences.

Characterization of antigens adsorbed to anionic PLG microparticles by XPS and TOF-SIMS.

C. Madden, Manmohan J. Singh, N. Patel, 2008, Journal of pharmaceutical sciences.

The potency of the adjuvant, CpG oligos, is enhanced by encapsulation in PLG microparticles.

Manmohan J. Singh, M. Ugozzoli, J. Chesko, 2008, Journal of pharmaceutical sciences.

A preliminary evaluation of alternative adjuvants to alum using a range of established and new generation vaccine antigens.

Manmohan J. Singh, M. Ugozzoli, J. Kazzaz, 2006, Vaccine.

An investigation of the factors controlling the adsorption of protein antigens to anionic PLG microparticles.

Manmohan J. Singh, M. Ugozzoli, J. Kazzaz, 2005, Journal of pharmaceutical sciences.

Modulating potency: Physicochemical characteristics are a determining factor of TLR4-agonist nanosuspension activity.

Magdalini Moutaftsi, T. Vedvick, Q. Dowling, 2014, Journal of pharmaceutical sciences.

Lyophilization and Stabilization of Vaccines

S. Reed, T. Vedvick, C. Fox, 2011 .

A modified process for preparing cationic polylactide-co-glycolide microparticles with adsorbed DNA.

Manmohan J. Singh, M. Hora, M. Ugozzoli, 2006, International journal of pharmaceutics.

Physicochemical characterization and biological activity of synthetic TLR4 agonist formulations.

R. Coler, S. Reed, T. Vedvick, 2010, Colloids and surfaces. B, Biointerfaces.

Adsorption of a Novel Recombinant Glycoprotein from HIV (Env gp120dV2 SF162) to Anionic PLG Microparticles Retains the Structural Integrity of the Protein, Whereas Encapsulation in PLG Microparticles Does Not

Manmohan J. Singh, I. Srivastava, E. Kan, 2004, Pharmaceutical Research.

Pyrazine: Supercollisions or simple reactions?

A. Suits, D. Stranges, J. Chesko, 1995 .

A comparison of anionic nanoparticles and microparticles as vaccine delivery systems

Manmohan J. Singh, Janet Wendorf, James Chesko, 2008, Human vaccines.

Polylactide-co-glycolide microparticles with surface adsorbed antigens as vaccine delivery systems.

Manmohan J. Singh, M. Ugozzoli, J. Kazzaz, 2006, Current drug delivery.